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accuracy derived from the experiment was: DD (5%) – 83.4% 
and 68% pixels passing, DTA (3mm) – 99.0% and 96,7%, gamma 
parameter (for DD (3%), DTA (3mm)) – 90% and 75,5% 
respectively for AAA and PBC algorithms. The comparison 
between studied parameters DD, DTA and γ for both 
algorithms implicated AAA as an appropriate approach 
in radiotherapy treatment planning. 
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The effect of nuclear fragmentation in the passage of 180MeV 
protons through the human body tissue is discussed. Prostate 
cancer protontherapy with these intermediate-energy 
protons is discussed in light of model calculation. 
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Rationale: An alternative approach for the improvement of 
radiotherapy consists in increasing differentially the radiation 
dose between tumors and healthy tissues using nanoparticles 
(NPs) that have been beforehand internalized into the tumor. 
These high-Z NPs can be photo-activated by monochromatic 
synchrotron X-rays, leading to a local dose enhancement 
delivered to the neighboring tumor cells[1]. This 
enhancement is due to secondary and Auger electrons 
expelled from the NPs by the radiations. In order to carry the 
NPs into the tumor center, macrophages are currently under 
study for their phagocytosis and diapedesis abilities[2] (cf. 
Figure adapted from [3] and [4]). In this study we 
characterized J774A.1 macrophages’ internalization kinetics 
and subcellular distribution of iron NPs and compared them 
to the internalization abilities of the F98 glioblastoma cell 
line. 
Materials and Methods: Three aspects of internalization were 
examined: first, the location of internalized NPs in J774A.1 
macrophages and F98 glioblastoma cells following a 24h 
incubation with iron NPs (0.3 mg/mL in the cell culture 
medium) was determined by optical microscopy after cell 
slicing. Subsequently, the iron intake after a 24h incubation 
with NPs (0.3 mg/mL and 0.06 mg/mL in the cell culture 
medium) was characterized for the two types of cells using 
ICP-MS. Finally, the internalization dynamics were studied by 
live phase-contrast microscopy imagining for 11 hours and by 
absorbance measurements for 24 hours using a plate reader. 
Results: F98 tumor cells and J774A.1 macrophages are both 
able to endocytose NPs: we measured ~61±10 pg of 
internalized iron per macrophage compared with ~33±5 pg 
per F98 cell (initial iron concentration: 0.3 mg/mL in culture 
medium). F98 internalizing NPs for 10 hours showed stress 
signs during the first minutes after the NPs injection, but 
behaved like F98 control cells during the rest of the 
experiment. Finally, we determined that the internalization 
kinetics for J774A.1 had a typical saturation time of one 
hour. 
Conclusion: Macrophages seem to be promising vectors for 
NPs, being able to endocytose and retain in their cytoplasm 
larger quantities of NPs than tumor cells. Our following 
studies will attempt to shed light on their other potential 
abilities as “Trojan Horses”. 
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Purpose: To improve precision of particle therapy, in vivo 
range verification is highly desirable. Methods based on 
prompt gamma rays emitted during treatment seem 
promising but have not yet been applied clinically. Here we 
report on the worldwide first clinical application of prompt 
gamma imaging (PGI) based range verification. 
Material / Methods: A prototype of a knife-edge shaped slit 
camera [1,2] was used to measure the prompt gamma ray 
depth distribution during a proton treatment of a head and 
neck tumor for seven consecutive fractions and one of three 
fields. The treatment was delivered with passively double 
scattered proton therapy (DS), although the slit camera was 
originally developed for pencil beam scanning. Before clinical 
application, the feasibility of the DS applicability was shown 
in a separate work [3], e.g. by introducing subtraction of the 
neutron-induced background. Inter-fractional variations of 
the prompt gamma profile were evaluated for the time 
integrated prompt gamma profile (sum profile) as well as for 
prompt gamma profiles corresponding to different steps of 
the modulator wheel (iso-energy layer resolved profile). For 
three fractions in-room control CTs were acquired and 
evaluated for dose relevant changes. 
Results: The measurement of PGI profiles during proton 
treatment was successful. Based on the PGI information of 
the sum profiles, inter-fractional global range variations, 
determined with automated shift detection, were in the 
range of ±2 mm for all evaluated fractions. This is within the 
uncertainty of the PGI system, as already the position 
accuracy of the PGI slit camera was determined with 1.1 mm 
(2σ). The detected range variations are in agreement with 
the control CT evaluation showing negligible range variations 
of about 1.5 mm. Also the evaluation of the iso-energy layer 
resolved prompt gamma profiles was in consistence with the 




Figure 1: Detected PGI sum profiles for 5 fractions (Fx) after 
application of a Gaussian filter (FWHM=20 mm). The region 
between 20k-50k counts was used for automated shift 
detection. Please note that for two fractions no data were 
available - one was used for a background measurement with 
closed slit (Fx 3), and for another one (Fx 1) a deficient 
background subtraction disturbed the sum profile. 
Conclusions: For the first time, range verification based on 
prompt gamma imaging was applied for a clinical proton 
treatment. Further plans include the continuation of the 
clinical study to perform systematic evaluations based on an 
appropriate patient number. With the translation from basic 
physics experiments into clinical operation, the authors are 
confident that a prompt gamma ray based technology is 
capable of range verification and can be used in the near 
future for online quality assurance as well as in midterm for 
potential margin reduction. 
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Purpose: In order to guarantee the best outcome of a 
therapeutic irradiation with protons and other light ions a 
non-invasive in-vivo range verification is desired. One 
approach in this field is Prompt γ-ray Imaging (PGI). A 
possible detection system for the prompt γ-rays is the 
Compton camera. Several groups have been working on the 
construction of Compton camera prototypes [1-5]. Up to now, 
Compton cameras have not been used in clinical practice for 
the monitoring of particle therapy. By means of Geant4 
simulations, we performed an end-to-end test to evaluate 
the clinical applicability of a Compton camera detection 
system and to determine the requirements regarding 
hardware and image reconstruction. 
Materials/methods: First, a treatment plan for a therapeutic 
proton irradiation for the head-neck region was prepared 
using XiO (Electa AB, Sweden). Based on this treatment plan, 
the γ-ray emissions from the patient's tissue were simulated 
with Geant4. As a next step, the detector response was 
modelled, also with Geant4, for two large Compton cameras 
arranged around the patient in an angle of 90 degrees. Large-
area detectors were already recommended [6]. Each camera 
was built up from a scatter layer (CZT) of dimension 10 × 10 
× 0.5 cm3 and an absorber layer (LSO) of size 20 × 20 × 2 cm3. 
In practice, these cameras would be replaced by several 
smaller camera modules. For the simulation of the detector 
response a total number of previously simulated γ-ray 
emissions were used as input corresponding to an applied 
dose of 1 Gy, i.e. a common dose of one field of one 
treatment session. After extracting the resulting coincident 
events, the image was reconstructed using a 3D MLEM 
algorithm [7]. The impact of the number of events, filters, as 
well as background on the image quality was also studied. 
 
Results: Figure 1 shows the images for the planned dose, the 
distribution of the γ-ray emissions and the reconstructed 
image obtained with 128 iterations of the MLEM algorithm. 
For the considered number of events and the chosen voxels 
